Uptravi

Tablet, Coated · Oral, Intravenous

Prescription (Rx) Prostacyclin Receptor Agonist

No FDA structured label text is available for Uptravi. The NDC listings below come from the FDA National Drug Code directory.

Active ingredients

Uptravi NDC products (17)

NDCStrength & formLabelerType
46014-6060Selexipag .6 mg/1
Capsule		Excella GmbH & Co. KGDRUG FOR FURTHER PROCESSING
46014-6100Selexipag 1 mg/1
Capsule		Excella GmbH & Co. KGDRUG FOR FURTHER PROCESSING
46014-6120Selexipag 1.2 mg/1
Capsule		Excella GmbH & Co. KGDRUG FOR FURTHER PROCESSING
46014-6140Selexipag 1.4 mg/1
Capsule		Excella GmbH & Co. KGDRUG FOR FURTHER PROCESSING
46014-6160Selexipag 1.6 mg/1
Capsule		Excella GmbH & Co. KGDRUG FOR FURTHER PROCESSING
46014-6040Selexipag .4 mg/1
Capsule		Excella GmbH & Co. KGDRUG FOR FURTHER PROCESSING
66215-915Selexipag 150 ug/1
Tablet, Film Coated		Actelion Pharmaceuticals US, Inc.NDA
66215-910Selexipag 100 ug/1
Tablet, Film Coated		Actelion Pharmaceuticals US, Inc.NDA
66215-718Selexipag 1800 ug/10mL
Injection, Powder, For Solution		Actelion Pharmaceuticals US, Inc.NDA
66215-616Selexipag 1600 ug/1
Tablet, Coated		Actelion Pharmaceuticals US, Inc.NDA
66215-614Selexipag 1400 ug/1
Tablet, Coated		Actelion Pharmaceuticals US, Inc.NDA
66215-612Selexipag 1200 ug/1
Tablet, Coated		Actelion Pharmaceuticals US, Inc.NDA
66215-610Selexipag 1000 ug/1
Tablet, Coated		Actelion Pharmaceuticals US, Inc.NDA
66215-608Selexipag 800 ug/1
Tablet, Coated		Actelion Pharmaceuticals US, Inc.NDA
66215-606Selexipag 600 ug/1
Tablet, Coated		Actelion Pharmaceuticals US, Inc.NDA
66215-604Selexipag 400 ug/1
Tablet, Coated		Actelion Pharmaceuticals US, Inc.NDA
66215-602Selexipag 200 ug/1
Tablet, Coated		Actelion Pharmaceuticals US, Inc.NDA

Frequently asked questions

Who makes Uptravi?

Uptravi is listed by 2 labelers in the FDA NDC directory, including Excella GmbH & Co. KG, Actelion Pharmaceuticals US, Inc..